- Share.Market
- 4 min read
- Published at : 07 May 2025 01:58 PM
- Modified at : 07 May 2025 02:01 PM
Here’s a quick summary of the financial performance and key highlights for Kansai Nerolac, Godrej Consumer Products, Poly Medicure, HPCL, and Piramal Enterprises.
Q4FY25
Revenue ₹1,816.7 crores 🔼 2.7%
PAT ₹102.4 crores 🔻 10.4%
FY25
Revenue ₹7,823 crores 🔼 0.3%
PAT ₹1,109.3 crores 🔻 5.7%
Performance remained muted with stable demand in the automotive segment, decrease in crude oil price and rural demand recovery.
Q4FY25
Revenue ₹3,597.95 crores 🔼 6.27%
PAT ₹411.90 crores (vs. loss of ₹1,893 crore in Q4FY24)
FY25
Revenue: ₹14,364 crores 🔼 2.22%
PAT ₹1,852.30 crores (vs. loss of ₹561 crore in Q4)
Godrej Consumer Products returned to profitability in Q4 and FY25 after losses last year, supported by volume growth in core markets. Q4FY25 consolidated organic sales grew by 7% in INR terms, with underlying volume growth of 6%.
India business volumes grew by 4%, Indonesia by 5%, and Africa/USA/Middle East sales surged 23% in INR terms. The Household Insecticides business in India saw strong double-digit volume growth. Home care in India grew 14% and personal care by 4% in Q4FY25
The Board declared an interim dividend of ₹5 per share for FY26.
Q4FY25
Revenue ₹440.8 crores 🔼 16.6%
PAT ₹91.8 crores 🔼 34.3%
FY25
Revenue ₹1,669.8 crores 🔼 21.4%
PAT ₹338.6 crores 🔼 31.1%
Poly Medicure delivered strong double-digit growth in revenue and PAT in both Q4 and FY25. The strong growth momentum was driven by higher demand for medical devices and expansion in international markets.
Q4FY25
Revenue ₹1,18,334 crores 🔻 2.6%
PAT ₹3,355 crores 🔼 18%
Domestic sales 12.7 MMT 🔼 3%
FY25
Revenue ₹4,66,346 crores 🔼 1%
PAT ₹7,365 crores 🔻 49.9%
Record sales volume 49.82 MMT 🔼 6.4%
HPCL achieved highest-ever quarterly and annual refinery throughput. Domestic sales volume grew by 2.7% YoY in Q4, outpacing industry growth. The company saw improved gross refining margins ($8.44/bbl in Q4 vs $6.95/bbl YoY), successful execution of major projects and expansion of infrastructure.
The Board recommended a final dividend of ₹10.5 per share, subject to approval of shareholders.
Q4FY25
Total Income ₹1,341 crores 🔼 24%
PAT ₹102 crores 🔻 25.5%
FY25
Total Income ₹4,595 crores 🔼 39%
Total AUM ₹80,689 crores 🔼 17%
PAT ₹485 crores (vs loss of ₹1,684 crores in FY24)
Piramal Enterprises completed its transformation into a focused NBFC, achieving strong AUM growth, improved asset quality, and a turnaround in profitability.
Note: The stocks and the prices mentioned are as of 1:55 PM.
Disclaimer
Investments in securities market are subject to market risks, read all the related documents carefully before investing. This is for informational purposes and should not be considered as recommendations.
Kindly refer to https://share.market/ for more details.
PhonePe Wealth Broking Private Limited is a member of NSE & BSE with SEBI Regn. No.: INZ000302639, Depository Participant of CDSL Depository with SEBI Regn. No.: IN-DP-696-2022, Research Analyst with SEBI Regn No: INH000013387, BSE RA Enlistment Number: 5887, and Mutual Fund distributor with AMFI Registration No: ARN- 187821. Member ID: BSE- 6756, NSE- 90226.
Registration granted by SEBI, enlistment as Research Analyst, and Certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors
Registered office – 2, Floor 3, Wing A, Block A, Salarpuria Softzone, Service Road, Green Glen Layout, Bellandur, Bengaluru South, Bengaluru, Karnataka – 560103, INDIA.
CIN: U65990KA2021PTC146954.